Cargando…
Diagnostic value of using a combination of nucleic acid and specific antibody tests for SARS-CoV-2 in coronavirus disease 2019
Coronavirus disease 2019 (COVID-19) is a newly emerged disease with various clinical manifestations and imaging features. The diagnosis of COVID-19 depends on a positive nucleic acid amplification test by real-time reverse transcription-polymerase chain reaction (RT-PCR) for severe acute respiratory...
Autores principales: | Zhao, Kaochang, Ai, Li, Zhao, Yang, Wang, Tao, Zheng, Zhishui, Zeng, Shaolin, Ding, Xuhong, Hu, Suping, Nie, Hanxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985888/ https://www.ncbi.nlm.nih.gov/pubmed/33594967 http://dx.doi.org/10.1017/S0950268821000406 |
Ejemplares similares
-
Clinical features in 52 patients with COVID-19 who have increased leukocyte count: a retrospective analysis
por: Zhao, Kaochang, et al.
Publicado: (2020) -
Paroxetine protects against bleomycin-induced pulmonary fibrosis by blocking GRK2/Smad3 pathway
por: Zhao, Kaochang, et al.
Publicado: (2023) -
Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019
por: Jin, Yujiao, et al.
Publicado: (2020) -
An Overview of Nucleic Acid Testing for the Novel Coronavirus SARS-CoV-2
por: Wang, Huiling, et al.
Publicado: (2021) -
Diagnostic value of combined nucleic acid and antibody detection in suspected COVID-19 cases
por: Zeng, H., et al.
Publicado: (2020)